AMPH
Amphastar Pharmaceuticals, Inc.
25.40$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 40.0% | 46.0% | 49.2% | 47.8% | 46.0% | 53.5% | 50.0% | 50.4% | 48.6% | 53.2% | 58.9% | 49.2% | 52.3% | |
| 60.0% | 54.0% | 50.8% | 52.2% | 54.0% | 46.5% | 50.0% | 49.6% | 51.4% | 46.8% | 41.1% | 50.8% | 47.7% | |
| 9.2% | 11.5% | 8.3% | 9.7% | 11.2% | 9.7% | 11.8% | 11.5% | 11.7% | 12.7% | 15.6% | 12.1% | 13.0% | |
| 7.0% | 7.4% | 9.1% | 7.3% | 7.8% | 6.9% | 9.4% | 8.0% | 20.6% | 9.0% | 10.5% | 9.9% | 12.6% | |
| 19.8% | 23.7% | 22.9% | 21.9% | 23.8% | 22.3% | 28.1% | 25.4% | 38.2% | 27.3% | 33.1% | 29.2% | 32.0% | |
| 40.3% | 30.3% | 27.9% | 30.3% | 30.2% | 24.2% | 21.9% | 24.2% | 13.2% | 19.4% | 8.0% | 21.6% | 15.7% | |
| 7.6% | 5.3% | 5.0% | 4.7% | 3.5% | 3.4% | 3.7% | 3.6% | 3.3% | 3.6% | 3.8% | 3.6% | 3.6% | |
| 35.0% | 22.9% | 27.5% | 27.5% | 25.3% | 23.6% | 18.1% | 22.6% | 11.2% | 17.4% | 5.9% | 21.0% | 14.0% | |
| 7.8% | 2.6% | 2.4% | 6.7% | 3.8% | 3.2% | 3.3% | 4.8% | 2.2% | 4.1% | 2.1% | 4.5% | 3.2% | |
| 27.3% | 20.3% | 25.1% | 20.8% | 21.4% | 20.4% | 14.8% | 17.8% | 9.0% | 13.3% | 3.8% | 16.5% | 10.8% | |
| 50.4% | 36.3% | 40.7% | 40.0% | 36.4% | 34.9% | 30.7% | 35.5% | 21.9% | 29.8% | 19.3% | 24.6% | 23.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.